Latest news articles

Added 1 day ago Drug news

Basilea licenses ARQ 087 from ArQule Inc for non Chinese markets as a treatment for biliary cancer.

Basilea Pharmaceutica Ltd. announced that it has entered into a license agreement with ArQule, Inc. for its oncology drug candidate...

Added 18 days ago Drug news

Positive results for Phase III REACH-2 study of Cyramza a treatment for liver cancer.- Eli Lilly.

Eli Lilly and Company announced top-line results from its Phase III REACH-2 study of Cyramza (ramucirumab) as a single agent...

Search all news articles for Cancer of liver and bile duct
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Transplantation

Transplantation

See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Oral Anticoagulation Reversal

Oral Anticoagulation Reversal

Experts discuss the use of non-vitamin K oral anticoagulants in the treatment and prevention of stroke, deep vein thrombosis and pulmonary embolism in atrial fibrillation patients.

Load more

Guidelines

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

These guidelines focus on diagnosis and pathology/molecular biology, staging and risk assessment and management of biliary cancer including follow-up and long-term implications.

Added 7 years ago

EASL Clinical Practice Guidelines: Liver transplantation

This Clinical Practice Guideline (CPG) has been developed to assist physicians and other healthcare providers during the evaluation process of candidates for LT and to help them in the correct management of patients after LT.

Added 2 years ago

Hepatocellular carcinoma: ESMO–ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

A joint guideline covering chapters on incidence and epidemiology, diagnosis and pathology, staging, management of local disease, management of locally advanced/metastatic disease, response evaluation and follow-up.

Added 5 years ago

Search all guidelines for Cancer of liver and bile duct
 

Journal articles

The role of liver resection in the management of intermediate and advanced stage hepatocellular carcinoma. A systematic review.

Background: The ideal management for patients with intermediate and advanced stage hepatocellular carcinoma (HCC) is controversial. The main purpose of this systematic review is to examine the role of liver resection...

Added 3 months ago

Interaction of margin status and tumour burden determines survival after resection of colorectal liver metastases: A retrospective cohort study.

Purpose: We sought to determine the impact of surgical margin status on overall survival (OS) and recurrence pattern stratified by tumor burden.

Added 3 months ago

CEACAM1 is associated with recurrence after hepatectomy for colorectal liver metastasis.

Background: Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is re-expressed at the invasion front of colorectal cancer. CEACAM1 expression at metastatic sites remains to be investigated.

Added 4 months ago

Search all journal articles for Cancer of liver and bile duct
 

Clinical trials

COLLISION Trial - Colorectal Liver Metastases: Surgery vs Thermal Ablation (COLLISION)

The primary objective is to prove non-inferiority of thermal ablation compared to hepatic resection in patients with at least one resectable and ablatable colorectal liver metastases (≤3cm) and no extrahepatic disease.

Added 5 months ago

Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma

This study involves a course of radiation to up to 5 tumors in the participant's liver followed by systemic therapy (Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body).

Added 1 year ago

Efficacy and Tolerability of Hemopatch After Hepatic Resection

• Previous in vitro and in vivo studies detected the Hemopatch Sealing Hemostat® to be a new versatile, self-adhering hemostatic sealing pad consisting of a polyethylene glycol-coated collagen.

Added 5 months ago

Search all clinical trials for Cancer of liver and bile duct
 
Alex Keen

Alex studied Biological Sciences at university before joining EPG Health in January 2017, where he works as a digital content manager and editor.

In his spare time, Alex enjoys relaxing with a cool pint in the company of good friends. 

ILC 2018 – Targetable pathways in liver disease: from identification to clinical application

A number of studies from the speakers at this year's ILC Basic Science Seminar are discussed here, focusing on targetable pathways in liver disease, covering pathway identification, potential drug targets and their clinical application.